{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:26:24Z","timestamp":1787725584562,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"DOI":"10.1007\/s10157-026-02936-4","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:52:37Z","timestamp":1787723557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world long-term outcomes and safety of avacopan for antineutrophil cytoplasmic antibody-associated vasculitis with advanced renal dysfunction: a multicenter cohort study (4U-AAV Study)"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4604-9478","authenticated-orcid":false,"given":"Kumiko","family":"Muta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"torigoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineaki","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"1","key":"2936_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2012","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2012;65(1):1\u201311.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2936_CR2","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/ndt\/gfac320","volume":"38","author":"B S\u00e1nchez \u00c1lamo","year":"2023","unstructured":"S\u00e1nchez \u00c1lamo B, Moi L, Bajema I, Faurschou M, Flossmann O, Hauser T, et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2023;38(7):1655\u201365.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"2936_CR3","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/ndt\/gfae018","volume":"39","author":"B Sachez-Alamo","year":"2024","unstructured":"Sachez-Alamo B, Moi L, Bajema I, Berden A, Flossmann O, Hruskova Z, et al. Long-term outcome of kidney function in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2024;39(9):1483\u201393.","journal-title":"Nephrol Dial Transplant"},{"key":"2936_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1545546","volume":"16","author":"A Fassio","year":"2025","unstructured":"Fassio A, Berti A, Mantovani A, Adami G, Pollastri F, Gatti D, et al. Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis. Front Immunol. 2025;16:1545546.","journal-title":"Front Immunol"},{"issue":"3","key":"2936_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/mr\/road081","volume":"34","author":"KE Sada","year":"2023","unstructured":"Sada KE, Nagasaka K, Kaname S, Nango E, Kishibe K, Dobashi H, et al. Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: the 2023 update - secondary publication. Mod Rheumatol. 2023;34(3):559\u201367.","journal-title":"Mod Rheumatol"},{"issue":"9","key":"2936_CR6","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.ekir.2024.07.007","volume":"9","author":"J Zimmermann","year":"2024","unstructured":"Zimmermann J, Sonnemann J, Jabs WJ, Sch\u00f6nermarck U, Vielhauer V, Bieringer M, et al. Avacopan in anti-neutrophil cytoplasmic autoantibodies-associated vasculitis in a real-world setting. Kidney Int Rep. 2024;9(9):2803\u20138.","journal-title":"Kidney Int Rep"},{"issue":"11","key":"2936_CR7","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3899\/jrheum.2024-0340","volume":"51","author":"T Uchida","year":"2024","unstructured":"Uchida T, Fukui S, Iwamoto N, Umetsu A, Okamoto M, Fujikawa K, et al. Absence of glucocorticoids concomitant with avacopan and subsequent liver injury in antineutrophil cytoplasmic antibody-associated vasculitis. J Rheumatol. 2024;51(11):1146\u20138.","journal-title":"J Rheumatol"},{"issue":"12","key":"2936_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s10157-021-02096-7","volume":"25","author":"J Usui","year":"2020","unstructured":"Usui J, Kawashima S, Sada KE, Miyawaki Y, Nakazawa D, Itabashi M, et al. A digest of the evidence-based clinical practice guideline for rapidly progressive glomerulonephritis 2020. Clin Exp Nephrol. 2020;25(12):1286\u201391.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"2936_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt WM, Pu\u00e9chal X, Fujimoto S, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382(7):622\u201331.","journal-title":"N Engl J Med"},{"issue":"12","key":"2936_CR10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham vasculitis activity score (version 3). Ann Rheum Dis. 2009;68(12):1827\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2936_CR11","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1002\/acr.24958","volume":"75","author":"P Delvino","year":"2023","unstructured":"Delvino P, Sardanelli F, Monti S, Cohen P, Pu\u00e9chal X, Mouthon L, et al. Remission and low disease activity in granulomatosis with polyangiitis and microscopic polyangiitis: prevalence and impact on damage accrual. Arthritis Care Res (Hoboken). 2023;75(5):1158\u201365.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"21","key":"2936_CR12","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, et al. Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial. JAMA. 2021;325(21):2178\u201387.","journal-title":"JAMA"},{"issue":"3","key":"2936_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/hep.32689","volume":"77","author":"RJ Fontana","year":"2023","unstructured":"Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W, et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023;77(3):1036\u201365.","journal-title":"Hepatology"},{"key":"2936_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17010014","author":"G Danan","year":"2015","unstructured":"Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2015. https:\/\/doi.org\/10.3390\/ijms17010014.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2936_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.ekir.2024.03.022","volume":"9","author":"R Zonozi","year":"2024","unstructured":"Zonozi R, Aqeel F, Le D, Cortazar FB, Thaker J, Zabala Ramirez MJ, et al. Real-world experience with avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int Rep. 2024;9(6):1783\u201391.","journal-title":"Kidney Int Rep"},{"issue":"4","key":"2936_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.103753","volume":"11","author":"I Berke","year":"2026","unstructured":"Berke I, Keller F, Untersulzner C, Shin JI, Park PG, Oh SS, et al. Systematic review of efficacy and safety of avacopan in real-world clinical practice. Kidney Int Rep. 2026;11(4):103753.","journal-title":"Kidney Int Rep"},{"issue":"2","key":"2936_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/ard-2024-226339","volume":"84","author":"S Nagle","year":"2025","unstructured":"Nagle S, Nguyen Y, Guerry MJ, Quemeneur T, Titeca-Beauport D, Cr\u00e9pin T, et al. Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis. Ann Rheum Dis. 2025;84(2):319\u201328.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2936_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41927-025-00456-4","volume":"9","author":"G Tagami","year":"2025","unstructured":"Tagami G, Yamaguchi M, Sugiyama H, Kinashi H, Imai K, Kamiya K, et al. Efficacy and safety of avacopan in antineutrophil cytoplasmic autoantibody-associated vasculitis: a retrospective cohort study in Japan. BMC Rheumatol. 2025;9(1):8.","journal-title":"BMC Rheumatol"},{"issue":"5","key":"2936_CR19","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/rheumatology\/keae689","volume":"64","author":"K Mori","year":"2025","unstructured":"Mori K, Shirai T, Mutoh T, Inoue J, Fujishima F, Kubo S, et al. Drug-induced liver injury related to avacopan therapy. Rheumatology (Oxford). 2025;64(5):2533\u201340.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"2936_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2169\/internalmedicine.5043-24","volume":"65","author":"M Hishinuma","year":"2026","unstructured":"Hishinuma M, Hasegawa M, Minatoguchi S, Umeda R, Koide S, Hayashi H, et al. Vanishing bile duct syndrome caused by a treatment regimen including avacopan for microscopic polyangiitis. Intern Med. 2026;65(7):1017\u201322.","journal-title":"Intern Med"},{"issue":"1","key":"2936_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2568971","volume":"47","author":"Z Yang","year":"2025","unstructured":"Yang Z, Wang C, Wei S, Liu Y, He M, Zheng C, et al. Post-marketing safety profile and clinical prioritization of adverse events with avacopan in ANCA-associated vasculitis: a FAERS pharmacovigilance analysis. Ren Fail. 2025;47(1):2568971.","journal-title":"Ren Fail"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02936-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02936-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:52:37Z","timestamp":1787723557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02936-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":21,"alternative-id":["2936"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02936-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no conflict of interest exists.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board of Nagasaki University Hospital, the principal research institute coordinating this study, approved the study protocol (registration number: 22080813\u20136). This study was approved by the institutional review boards and ethics committees of the participating institutes.","order":2,"name":"Ethics","label":"Human and animal rights","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Owing to the retrospective design of the study, the respective ethics committees waived the need to obtain informed consent, and the patients were informed by the respective centers that they could opt out of the study if they wished.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}